PL1896019T3 - Preparat tienopirydynowego inhibitora agregacji płytek - Google Patents
Preparat tienopirydynowego inhibitora agregacji płytekInfo
- Publication number
- PL1896019T3 PL1896019T3 PL06772240T PL06772240T PL1896019T3 PL 1896019 T3 PL1896019 T3 PL 1896019T3 PL 06772240 T PL06772240 T PL 06772240T PL 06772240 T PL06772240 T PL 06772240T PL 1896019 T3 PL1896019 T3 PL 1896019T3
- Authority
- PL
- Poland
- Prior art keywords
- formulation
- platelet aggregation
- aggregation inhibitor
- thienopyridine
- thienopyridine platelet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68918305P | 2005-06-10 | 2005-06-10 | |
| PCT/US2006/021860 WO2006135605A2 (en) | 2005-06-10 | 2006-06-06 | Formulation of a thienopyridine platelet aggregation inhibitor |
| EP06772240A EP1896019B1 (en) | 2005-06-10 | 2006-06-06 | Formulation of a thienopyridine platelet aggregation inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1896019T3 true PL1896019T3 (pl) | 2010-01-29 |
Family
ID=37198935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06772240T PL1896019T3 (pl) | 2005-06-10 | 2006-06-06 | Preparat tienopirydynowego inhibitora agregacji płytek |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20080176893A1 (pl) |
| EP (1) | EP1896019B1 (pl) |
| JP (1) | JP2008543755A (pl) |
| KR (2) | KR20100076050A (pl) |
| CN (1) | CN101193633B (pl) |
| AR (1) | AR054283A1 (pl) |
| AT (1) | ATE441413T1 (pl) |
| AU (1) | AU2006258102B2 (pl) |
| BR (1) | BRPI0611350B8 (pl) |
| CA (1) | CA2611668C (pl) |
| CY (1) | CY1109502T1 (pl) |
| DE (1) | DE602006008942D1 (pl) |
| DK (1) | DK1896019T3 (pl) |
| DO (1) | DOP2006000126A (pl) |
| EA (1) | EA011693B1 (pl) |
| EC (1) | ECSP077984A (pl) |
| ES (1) | ES2330373T3 (pl) |
| HR (1) | HRP20090516T1 (pl) |
| IL (1) | IL187830A0 (pl) |
| MA (1) | MA29688B1 (pl) |
| MX (1) | MX2007015431A (pl) |
| MY (1) | MY151038A (pl) |
| NO (1) | NO20076317L (pl) |
| NZ (1) | NZ564003A (pl) |
| PE (1) | PE20070320A1 (pl) |
| PL (1) | PL1896019T3 (pl) |
| PT (1) | PT1896019E (pl) |
| RS (1) | RS51194B (pl) |
| SI (1) | SI1896019T1 (pl) |
| TN (1) | TNSN07466A1 (pl) |
| TW (1) | TWI318571B (pl) |
| UA (1) | UA91051C2 (pl) |
| WO (1) | WO2006135605A2 (pl) |
| ZA (1) | ZA200710697B (pl) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110201814A1 (en) * | 2006-12-07 | 2011-08-18 | Daiichi Sankyo Company Limited | Method for producing solid preparation |
| CN101594865A (zh) * | 2006-12-07 | 2009-12-02 | 第一三共株式会社 | 含有低取代的羟基丙基纤维素的药物组合物 |
| CA2672134C (en) * | 2006-12-07 | 2015-02-10 | Daiichi Sankyo Company, Limited | Solid medicinal preparation containing mannitol or lactose |
| US20090291138A1 (en) * | 2006-12-07 | 2009-11-26 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
| CN101568339A (zh) * | 2006-12-07 | 2009-10-28 | 伊莱利利公司 | 普拉格雷的制品 |
| KR101647842B1 (ko) * | 2006-12-07 | 2016-08-11 | 다이이찌 산쿄 가부시키가이샤 | 저장 안정성이 개선된 의약 조성물 |
| JP5363307B2 (ja) * | 2007-03-02 | 2013-12-11 | 第一三共株式会社 | 高純度のプラスグレル塩酸塩の製造方法 |
| RU2470636C2 (ru) | 2007-04-27 | 2012-12-27 | Сайдекс Фамэсьютиклз, Инк. | Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты) |
| GB2450117A (en) * | 2007-06-13 | 2008-12-17 | Reckitt Benckiser Healthcare | A water- and oxygen-occlusive blister tablet pack |
| DE112009000268T5 (de) | 2008-02-06 | 2011-06-01 | Helm Ag | Prasugrel-Salze mit verbesserten Eigenschaften |
| EP2107061A1 (en) * | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
| EP2112155B1 (en) | 2008-04-25 | 2010-09-29 | Sandoz AG | Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation |
| WO2010094471A1 (en) * | 2009-02-17 | 2010-08-26 | Krka, D. D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
| DK3100728T3 (da) | 2009-05-13 | 2020-02-17 | Cydex Pharmaceuticals Inc | Farmaceutiske sammensætninger omfattende prasugrel og cyclodextrin-derivativ og fremgangsmåder til fremstilling og brug af samme |
| DE102009036646A1 (de) | 2009-08-07 | 2011-02-10 | Ratiopharm Gmbh | Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon |
| WO2011052499A1 (ja) * | 2009-10-28 | 2011-05-05 | 第一三共株式会社 | 貯蔵安定性が改善された医薬組成物 |
| JP2013032289A (ja) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | ワックス安定製剤 |
| WO2011092720A2 (en) * | 2010-02-01 | 2011-08-04 | Msn Laboratories Limited | Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts |
| TR201007926A1 (tr) | 2010-07-19 | 2012-02-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Prasugrel tablet formülasyonları. |
| EP2409685A3 (en) | 2010-07-19 | 2012-02-01 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orally-disintegrating formulations of prasugrel |
| TR201005900A1 (tr) | 2010-07-19 | 2012-02-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Geliştirilmiş stabiliteye sahip prasugrel granülleri. |
| TR201006802A1 (tr) * | 2010-08-17 | 2012-03-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Prasugrelin oral yolla dağılan formülasyonları. |
| CZ2011872A3 (cs) | 2011-12-22 | 2013-07-03 | Zentiva, K.S. | Farmaceutická formulace prasugrelu hydrobromidu |
| US8603537B2 (en) | 2012-04-02 | 2013-12-10 | Egis Pharmaceuticals Plc | Prasugrel containing quickly released stable oral pharmaceutical compositions |
| WO2014060554A1 (en) | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Prasugrel formulations |
| WO2014060560A1 (en) | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Solid oral formulations of prasugrel |
| CN102993210A (zh) * | 2012-12-19 | 2013-03-27 | 苏春华 | 一种吡啶并噻吩的新化合物 |
| EP2979693A1 (en) | 2014-08-01 | 2016-02-03 | Zaklady Farmaceutyczne Polpharma SA | Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation |
| WO2016122421A1 (en) | 2015-01-29 | 2016-08-04 | Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. | Stable pharmaceutical compositions containing prasugrel base |
| EP3158993A1 (en) | 2015-10-22 | 2017-04-26 | Zaklady Farmaceutyczne Polpharma SA | Process for preparing a tablet comprising prasugrel or pharmaceutically acceptable salt thereof |
| CN107304216A (zh) * | 2016-04-20 | 2017-10-31 | 陕西合成药业股份有限公司 | 噻吩吡啶类衍生物及其制备方法和用途 |
| HU231079B1 (hu) | 2016-06-23 | 2020-06-29 | Richter Gedeon Nyrt. | Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával |
| GR1009230B (el) | 2016-10-12 | 2018-02-22 | Φαρματεν Αβεε | Φαρμακευτικο σκευασμα που περιλαμβανει βεσυλικη πρασουγρελη |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI101150B (fi) * | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
| EP1298132B1 (en) * | 2000-07-06 | 2006-11-22 | Sankyo Company, Limited | Hydropyridine derivative acid addition salts |
| JP4001199B2 (ja) * | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
| EP1243524A3 (en) * | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| JP4394873B2 (ja) * | 2001-12-19 | 2010-01-06 | 武田薬品工業株式会社 | 酸素に不安定な化合物を含有する固形組成物およびその安定化方法 |
| SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
| US20050020554A1 (en) * | 2003-06-06 | 2005-01-27 | Ahmed Salah U. | Stability of hormone formulations |
| EP1653930B1 (en) * | 2003-08-05 | 2007-12-19 | Zentiva, a.s. | Methods for the stabilization of atorvastatin |
-
2006
- 2006-06-02 TW TW095119687A patent/TWI318571B/zh active
- 2006-06-06 DO DO2006000126A patent/DOP2006000126A/es unknown
- 2006-06-06 AT AT06772240T patent/ATE441413T1/de active
- 2006-06-06 KR KR1020107011742A patent/KR20100076050A/ko not_active Ceased
- 2006-06-06 KR KR1020077028749A patent/KR20080008413A/ko not_active Ceased
- 2006-06-06 EA EA200702670A patent/EA011693B1/ru not_active IP Right Cessation
- 2006-06-06 DE DE602006008942T patent/DE602006008942D1/de active Active
- 2006-06-06 US US11/913,889 patent/US20080176893A1/en not_active Abandoned
- 2006-06-06 SI SI200630490T patent/SI1896019T1/sl unknown
- 2006-06-06 UA UAA200712993A patent/UA91051C2/ru unknown
- 2006-06-06 CN CN2006800205289A patent/CN101193633B/zh active Active
- 2006-06-06 PT PT06772240T patent/PT1896019E/pt unknown
- 2006-06-06 MX MX2007015431A patent/MX2007015431A/es active IP Right Grant
- 2006-06-06 NZ NZ564003A patent/NZ564003A/en not_active IP Right Cessation
- 2006-06-06 PL PL06772240T patent/PL1896019T3/pl unknown
- 2006-06-06 CA CA2611668A patent/CA2611668C/en not_active Expired - Fee Related
- 2006-06-06 BR BRPI0611350A patent/BRPI0611350B8/pt active IP Right Grant
- 2006-06-06 EP EP06772240A patent/EP1896019B1/en not_active Revoked
- 2006-06-06 HR HR20090516T patent/HRP20090516T1/xx unknown
- 2006-06-06 RS RSP-2009/0425A patent/RS51194B/sr unknown
- 2006-06-06 ES ES06772240T patent/ES2330373T3/es active Active
- 2006-06-06 AU AU2006258102A patent/AU2006258102B2/en not_active Ceased
- 2006-06-06 WO PCT/US2006/021860 patent/WO2006135605A2/en not_active Ceased
- 2006-06-06 JP JP2008515813A patent/JP2008543755A/ja active Pending
- 2006-06-06 DK DK06772240T patent/DK1896019T3/da active
- 2006-06-08 PE PE2006000641A patent/PE20070320A1/es not_active Application Discontinuation
- 2006-06-09 AR AR20060102430A patent/AR054283A1/es unknown
- 2006-06-09 MY MYPI20062708 patent/MY151038A/en unknown
-
2007
- 2007-12-03 IL IL187830A patent/IL187830A0/en unknown
- 2007-12-07 TN TNP2007000466A patent/TNSN07466A1/en unknown
- 2007-12-07 NO NO20076317A patent/NO20076317L/no not_active Application Discontinuation
- 2007-12-07 EC EC2007007984A patent/ECSP077984A/es unknown
- 2007-12-07 ZA ZA200710697A patent/ZA200710697B/xx unknown
-
2008
- 2008-01-09 MA MA30568A patent/MA29688B1/fr unknown
-
2009
- 2009-10-22 CY CY20091101101T patent/CY1109502T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187830A0 (en) | Formulation of a thienopyridine platelet aggregation inhibitor | |
| PL2402317T3 (pl) | Inhibitor DGAT | |
| EP2007238A4 (en) | SHOE | |
| PT2094708E (pt) | Pirrolopirazina como inibidor da cinase syk | |
| PL3460022T3 (pl) | Kompozycje do stosowania jako czynnik chłodniczy | |
| IL192357A0 (en) | Pharmaceutical compositions containing a farnesyl transferase inhibitor | |
| IL187567A0 (en) | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor | |
| GB0504995D0 (en) | Use of a compound | |
| IL192954A0 (en) | Salt of cd 80 antagonist | |
| IL228986A0 (en) | A preparation that inhibits the aggregation of blood platelets | |
| GB0623381D0 (en) | Use of a compound as VEGF inhibitor | |
| EP1802280A4 (en) | CLOPIDOGREL COMPOSITIONS | |
| ZA200704797B (en) | Packaging of multiple consumer articles | |
| GB2429464B (en) | Manufacture of a ferrous article | |
| HK1119943A (en) | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor | |
| PL380677A1 (pl) | Nowa sól klopidogrelu | |
| GB0610609D0 (en) | Phillips rgfr | |
| GB0522829D0 (en) | Use of a compound | |
| GB0610626D0 (en) | World wide library | |
| GB0603398D0 (en) | Methods of manufacturing of extended area articles | |
| GB0622244D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0623958D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0622246D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0622245D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0620786D0 (en) | Use of a casein containing composition |